Presentation is loading. Please wait.

Presentation is loading. Please wait.

Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left.

Published byLuke Harmon Modified over 6 years ago

Similar presentations

Presentation on theme: "Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left."— Presentation transcript:

1 Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups.
From: Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients Eur J Cardiothorac Surg. 2011;40(4): doi: /j.ejcts Eur J Cardiothorac Surg | © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

2 Table 1 Demographic, clinical and hemodynamic parameters before LVAD implantation in the two groups.
From: Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients Eur J Cardiothorac Surg. 2011;40(4): doi: /j.ejcts Eur J Cardiothorac Surg | © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

3 Table 3 Hemodynamic parameters in patients with fixed PH before LVAD implantation (T<sub>1</sub>) and during assist support (T<sub>2</sub>). From: Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients Eur J Cardiothorac Surg. 2011;40(4): doi: /j.ejcts Eur J Cardiothorac Surg | © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

4 Table 4 Outcome of patients after LVAD implantation in the two groups.
From: Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients Eur J Cardiothorac Surg. 2011;40(4): doi: /j.ejcts Eur J Cardiothorac Surg | © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

5 Table 5 Literature data overview.
From: Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients Eur J Cardiothorac Surg. 2011;40(4): doi: /j.ejcts Eur J Cardiothorac Surg | © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.European Association for Cardio-Thoracic Surgery

Download ppt "Table 2 Laboratory and echocardiographic values before LVAD implantation in the two groups. From: Reversibility of fixed pulmonary hypertension in left."

Similar presentations

Fig.1 Complexity of the surgeries according to BAS. Histogram.

Fig.1 Complexity of the surgeries according to BAS. Histogram.
Figure 1: Animal preparation; a modified Glenn shunt was created between the SVC and the main pulmonary artery. A left ventricular assist device was implanted.

Figure 1: Animal preparation; a modified Glenn shunt was created between the SVC and the main pulmonary artery. A left ventricular assist device was implanted.
Fig. 1. TGF results in different group

Fig. 1. TGF results in different group
Table 1 Cause of death for arrested organ donors

Table 1 Cause of death for arrested organ donors
Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.

Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.
Figure 1 Patients outside of target international normalized ratio range by time point and management strategy. All values are expressed as percentages.

Figure 1 Patients outside of target international normalized ratio range by time point and management strategy. All values are expressed as percentages.
Fig. 1. Patient transferred to ICU with IABP inserted surgically through left axillary artery approached at deltoido-pectoralis groove (a). Correct position.

Fig. 1. Patient transferred to ICU with IABP inserted surgically through left axillary artery approached at deltoido-pectoralis groove (a). Correct position.
Figure 1: Forest plots. M-H: Mantel-Haenszel test; CI: confidence interval; SD: standard deviation; IV: inverse variance. Suction on chest drains following.

Figure 1: Forest plots. M-H: Mantel-Haenszel test; CI: confidence interval; SD: standard deviation; IV: inverse variance. Suction on chest drains following.
Table 1 Patient characteristics

Table 1 Patient characteristics
Fig. 1 Diagram of method C for bronchial closure

Fig. 1 Diagram of method C for bronchial closure
Figure 2: The Medical Imaging Projection System projecting the real-time fluorescent image on the surface of the lung during surgery (left). The cut surface.

Figure 2: The Medical Imaging Projection System projecting the real-time fluorescent image on the surface of the lung during surgery (left). The cut surface.
Fig. 1 Clinical model of coronary collateral flow

Fig. 1 Clinical model of coronary collateral flow
Table 1 Staging of resected tumours of the oesophagus

Table 1 Staging of resected tumours of the oesophagus
Fig. 4 The blood path conversion to VAD by relocating the tubing clamps. Stasis in the oxygenator is avoided by recirculating its volume, thus allowing.

Fig. 4 The blood path conversion to VAD by relocating the tubing clamps. Stasis in the oxygenator is avoided by recirculating its volume, thus allowing.
Figure 1 Representative transoesophageal echocardiographic images of ventricular fibrillation during cardiopulmonary bypass. (A) Mid-oesophageal aortic.

Figure 1 Representative transoesophageal echocardiographic images of ventricular fibrillation during cardiopulmonary bypass. (A) Mid-oesophageal aortic.
Figure 1: Correlation of plasma ET-1 levels with LAD in patients with mitral valve disease. r is Pearson’s correlation coefficient. ET-1: endothelin 1;

Figure 1: Correlation of plasma ET-1 levels with LAD in patients with mitral valve disease. r is Pearson’s correlation coefficient. ET-1: endothelin 1;
Table 1 Baseline characteristics of mitral valve operated patientsaaAF, atrial fibrillation; LA, left atrium; LVEDD, left ventricular end-diastolic.

Table 1 Baseline characteristics of mitral valve operated patientsaaAF, atrial fibrillation; LA, left atrium; LVEDD, left ventricular end-diastolic.
Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates  Daniel Zimpfer, MD, Philipp Zrunek, MS, Wilfried.

Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates  Daniel Zimpfer, MD, Philipp Zrunek, MS, Wilfried.
Table 1 Comparison of perioperative patient characteristics by groups

Table 1 Comparison of perioperative patient characteristics by groups
Fig. 1 Log-rank test comparing survival in patients undergoing surgical repair with those treated with TEVAR. Black line: TEVAR; grey line: surgical repair.

Fig. 1 Log-rank test comparing survival in patients undergoing surgical repair with those treated with TEVAR. Black line: TEVAR; grey line: surgical repair.

Similar presentations

Ads by Google